In a report released today, Thomas Smith from SVB Securities maintained a Buy rating on Axcella Health (AXLA β Research Report), with a price...
After Chardan Capital and Wedbush gave Axcella Health (NASDAQ: AXLA) a Buy rating last month, the company received another Buy, this time from...
In a report released today, Keay Nakae from Chardan Capital reiterated a Buy rating on Axcella Health (AXLA β Research Report), with a price...
0001633070 false 0001633070 2022-08-02 2022-08-02 iso4217:USD xbrli:shares...
FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...
Noble Financial analyst Robert LeBoyer maintained a Buy rating on Axcella Health (AXLA β Research Report) today and set a price target of $9.00...
After SVB Securities and Noble Financial gave Axcella Health (NASDAQ: AXLA) a Buy rating last month, the company received another Buy, this time...
0001633070 false 0001633070 2022-05-26 2022-05-26 iso4217:USD xbrli:shares...
0001633070 false 0001633070 2022-05-19 2022-05-19 iso4217:USD xbrli:shares...
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.